Skip to Content

BlackRock Sus Adg Intl Eq Inv A BRZAX

Medalist Rating as of | See BlackRock Investment Hub
  • NAV / 1-Day Return 11.97  /  +1.01 %
  • Total Assets 17.0 Mil
  • Adj. Expense Ratio
    0.750%
  • Expense Ratio 0.750%
  • Distribution Fee Level Low
  • Share Class Type Front Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 2.18%
  • Turnover 118%

USD | NAV as of Jul 05, 2024 | 1-Day Return as of Jul 05, 2024, 10:19 PM GMT+0

Morningstar’s Analysis BRZAX

Will BRZAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin BlackRock Sus Adg Intl Eq Inv A's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BRZAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 19.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

3.23 542,692
Healthcare

ASML Holding NV

2.91 488,741
Technology

BlackRock Liquidity T-Fund Instl

2.48 416,346
Cash and Equivalents

AstraZeneca PLC

1.98 333,376
Healthcare

Novartis AG Registered Shares

1.95 328,519
Healthcare

SAP SE

1.76 295,833
Technology

Shell PLC

1.75 293,420
Energy

Siemens AG

1.56 262,721
Industrials

Nestle SA

1.51 253,478
Consumer Defensive

Schneider Electric SE

1.50 252,352
Industrials